Overview

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of Tesomet (tesofensine + metoprolol) in subjects with PWS.
Phase:
Phase 2
Details
Lead Sponsor:
Saniona
Treatments:
Metoprolol